Biomedical subjects

Ravinder Nath

Publications and source records attributed to Ravinder Nath.

At least 37 records · Page 2Linked to original sources

PubMed2004

Modelling 6 MV photon beams of a stereotactic radiosurgery system for Monte Carlo treatment planning.

The goal of this work is to build a multiple source model to represent the 6 MV photon beams from a Cyberknife stereotactic radiosurgery system for Monte Carlo treatment planning dose calculations. To achieve this goal, the 6 MV photon beams have been characterized and modelled using the EGS4/BEAM Monte Carlo system. A dual source model has been used to reconstruct the particle phase space at a plane immediately above the secondary collimator. The proposed model consists of two circular planar sources for the primary photons and the scattered photons, respectively. The dose contribution of the contaminant electrons was found to be in the order of 10(-3) of the total maximum dose and therefore has been omitted in the source model. Various comparisons have been made to verify the dual source model against the full phase space simulated using the EGS4/BEAM system. The agreement in percent depth dose (PDD) curves and dose profiles between the phase space and the source model was generally within 2%/1 mm for various collimators (5 to 60 mm in diameter) at 80 to 100 cm source-to-surface distances (SSD). Excellent agreement (within 1%/1 mm) was also found between the dose distributions in heterogeneous lung and bone geometry calculated using the original phase space and those calculated using the source model. These results demonstrated the accuracy of the dual source model for Monte Carlo treatment planning dose calculations for the Cyberknife system.

Models, Theoretical↗

PubMed2004

Development of a rat solid tumor model for continuous low-dose-rate irradiation studies using 125I and 103Pd sources.

PURPOSE: To develop an experimental technique for studying the radiobiology of continuous low-dose-rate irradiation (CLDRI) using clinical brachytherapy sources emitting low energy photons for a rat solid tumor model. METHODS AND MATERIALS: BA1112 tumors were grown between the ears of 14-week-old male WAG/Rij rats by interdermal inoculation. A radioactive source afterloading system, which consists of a lightweight helmet sutured to the rat and a nine-source polystyrene applicator, was fabricated for in vivo tumor irradiation by (125)I and (103)Pd brachytherapy sources. This system has a 12 x 12 mm opening in the center to accommodate the tumor and its growth during irradiation (the diameter of a typical BA1112 tumor was about 6 mm when radiation was applied). The spatial locations of the nine sources were optimized to produce an as uniform as possible three-dimensional dose distribution to the central portion of the applicator for both the (125)I and (103)Pd sources. Absolute dose delivered by the applicator was verified by point dose measurements using calibrated TLD in a polystyrene phantom that mimics the scattering environment of the tumor on the rat. RESULTS: The feasibility of tumor cure experiments using the experimental technique presented in this work was demonstrated. The technique was used to study the influence of initial dose rate on the in vivo tumor cure probability of BA1112 tumors irradiated by (125)I and (103)Pd sources at dose rates varying from 8-20 cGy/h. The technique was also used for studying the in vitro tumor cell survival following in vivo CLDRI irradiation of the tumor. CONCLUSION: An experimental technique using an in vivo tumor model has been developed for studying the radiobiological effects of continuous low-dose-rate irradiations using (125)I sources alone, (103)Pd sources alone, or a mixture of (125)I and (103)Pd sources.

Animals↗

PubMed2004

A technique to re-establish dose distributions for previously treated brain cancer patients in external beam radiotherapy.

Tumor recurrences or new tumors may develop after irradiation of local lesion(s) in the brain, and additional radiotherapy treatments are often needed for previously treated patients. It is critical to re-establish the dose distributions delivered during the previous treatment in the current patient geometry, so that the previous dose distributions can be accurately taken into consideration in the design of the current treatment plan. The difficulty in re-establishing the previous treatment dose distributions in the current patient geometry arises from the fact that the patient position at the time of reirradiation is different from that at the previous treatment session. Simple re-entry of the previous isocenter coordinates, gantry, and couch and collimator angles into the new treatment plan would result in incorrect beam orientations relative to the new patient anatomy, and therefore incorrect display of the previous dose distributions on the current patient anatomy. To address this issue, a method has been developed so that the previous dose distributions can be accurately re-established in the framework of the current brain treatment. The method involves 3 matrix transformations: (1) transformation of beams from machine coordinate system to patient coordinate system in the previous treatment; (2) transformation of beams from patient coordinate system in the previous treatment to patient coordinate system in the current treatment; and (3) transformation of beams from patient coordinate system in the current treatment to machine coordinate system. The transformation matrices used in the second transformation are determined by registration using a mutual information-based algorithm with which the old and new computed tomography (CT) scan sets are registered automatically without human interpretation. A series of transformation matrices are derived to calculate the isocenter coordinates, the gantry, couch, and collimator angles of the beams for the previous treatment in the current patient geometry, and the previous dose distributions are re-established on the current CT images. The method has been proven to be successful and robust.

Algorithms↗

PubMed2004

Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.

Since publication of the American Association of Physicists in Medicine (AAPM) Task Group No. 43 Report in 1995 (TG-43), both the utilization of permanent source implantation and the number of low-energy interstitial brachytherapy source models commercially available have dramatically increased. In addition, the National Institute of Standards and Technology has introduced a new primary standard of air-kerma strength, and the brachytherapy dosimetry literature has grown substantially, documenting both improved dosimetry methodologies and dosimetric characterization of particular source models. In response to these advances, the AAPM Low-energy Interstitial Brachytherapy Dosimetry subcommittee (LIBD) herein presents an update of the TG-43 protocol for calculation of dose-rate distributions around photon-emitting brachytherapy sources. The updated protocol (TG-43U1) includes (a) a revised definition of air-kerma strength; (b) elimination of apparent activity for specification of source strength; (c) elimination of the anisotropy constant in favor of the distance-dependent one-dimensional anisotropy function; (d) guidance on extrapolating tabulated TG-43 parameters to longer and shorter distances; and (e) correction for minor inconsistencies and omissions in the original protocol and its implementation. Among the corrections are consistent guidelines for use of point- and line-source geometry functions. In addition, this report recommends a unified approach to comparing reference dose distributions derived from different investigators to develop a single critically evaluated consensus dataset as well as guidelines for performing and describing future theoretical and experimental single-source dosimetry studies. Finally, the report includes consensus datasets, in the form of dose-rate constants, radial dose functions, and one-dimensional (1D) and two-dimensional (2D) anisotropy functions, for all low-energy brachytherapy source models that met the AAPM dosimetric prerequisites [Med. Phys. 25, 2269 (1998)] as of July 15, 2001. These include the following 125I sources: Amersham Health models 6702 and 6711, Best Medical model 2301, North American Scientific Inc. (NASI) model MED3631-A/M, Bebig/Theragenics model I25.S06, and the Imagyn Medical Technologies Inc. isostar model IS-12501. The 103Pd sources included are the Theragenics Corporation model 200 and NASI model MED3633. The AAPM recommends that the revised dose-calculation protocol and revised source-specific dose-rate distributions be adopted by all end users for clinical treatment planning of low energy brachytherapy interstitial sources. Depending upon the dose-calculation protocol and parameters currently used by individual physicists, adoption of this protocol may result in changes to patient dose calculations. These changes should be carefully evaluated and reviewed with the radiation oncologist preceding implementation of the current protocol.

Air↗

PubMed2004

On the development of consensus values of reference dosimetry parameters for interstitial brachytherapy sources.

The American Association of Physicists in Medicine recommends that the reference dose-rate distribution, used for treatment planning for low-energy photon brachytherapy sources in routine clinical use, must be based on at least two independent determinations: one using experimentally measured dose rates and one using Monte Carlo simulation dosimetry techniques. In this work, we present an approach for developing consensus dosimetry parameters from various independent reference dosimetry studies for interstitial brachytherapy sources. This approach is applied to four recently published papers on the dosimetric properties of the BrachySeed Model LS-1 125I seed. Consensus values for the dose-rate constant, radial dose function, and anisotropy parameters are presented for the LS-1 Model 125I seed.

Algorithms↗

PubMed2004

Dosimetric characteristics of the Novoste Beta-Cath 90Sr/Y source trains at submillimeter distances.

Measurements were performed on the 30, 40, and 60 mm 90Sr/Y beta-emitter source trains used in the Novoste Beta-Cath system to determine their dosimetric characteristics at submillimeter distances and provide the necessary TG-60 parameters for mapping their dose distributions. These measurements were carried out in a Solid Water phantom where MD55-2 Gafchromic films were placed in direct contact with a 5 French (F) catheter used for the 30 and 60 mm source trains and a 3.5F catheter used for thinner 30 and 40 mm source trains. A data set consisted of three pieces of Gafchromic film irradiated for periods of 1.5, 5, and 10 minutes, respectively. This 3-film irradiation technique provided reliable dose data at short, intermediate and long distances from a source train. Three data sets per source train were collected in this study. For the 30 mm source train with a 5F catheter, data were collected with the source axis at proximal (0.41 mm) and distal (1.19 mm) positions to the film surface in order to investigate dosimetric effects due to the off centering of the source train lumen within the catheter. Absolute doses were determined by calibrating the Gafchromic film in a high-energy electron beam from a radiotherapy accelerator. The absolute dose rates at a distance of 2 mm along the source trains transverse axis were found to be within 13.7% of the values provided by Novoste. Radial dose functions were within 13% compared to 90Sr/Y source train data constructed from Soares' 90Sr/Y single seed data and within 17% and 25% compared to Monte Carlo data by Ye et al., and Wang et al., respectively. Discrepancies of 33% and 19% were observed at short radial distances (< or = 1 mm) between the Novoste Monte Carlo and the 3.5F and 5F catheter measured data, respectively. The source off centering data showed higher dose contribution from the source train at its distal rather than proximal position. Radial dose function comparisons between the Novoste Monte Carlo and the measured data, calculated as a function of radial distance from the catheter's center showed good agreement (< or = 10%).

Brachytherapy↗

PubMed2004

Optimization of dose distributions for bifurcated coronary vessels treated with catheter-based photon and beta emitters using the simulated annealing algorithm.

The dose distributions in the bifurcated vessels treated with a catheter-based delivery system are complicated by the geometry of bifurcation consisting of a main and a branch vessel at different angles, and it is difficult to generate satisfactory dose distributions. We hypothesize that increasing the number of dwell positions can result in better dose distributions. An optimization method based on the simulated annealing was developed to demonstrate the validity of this idea. In this method, the source in the branch treatment was allowed to take up to five dwell positions. A cost function was constructed to deliver the prescription dose to the planning targets with penalties for both overdosing and underdosing. By using the optimization algorithm, it was found that for 90 degrees to 60 degrees bifurcated vessels an optimized single dwell position treatment scheme can be as effective as the schemes that include up to five dwell positions. As the bifurcation angle becomes smaller than 60 degrees, the dose distributions generated with the single dwell position scheme become less satisfactory than the more complicated treatment schemes with multiple dwell positions. By using a three-dwell-position treatment scheme for the 192Ir source, the overdosing can be kept under 166% even at a bifurcation angle of 20 degrees.

Algorithms↗

PubMed2004

Near-field dosimetry of 125I sources for interstitial brachytherapy implants measured using thermoluminescent sheets.

The dosimetric characteristics were measured for two types of 125I low-energy photon-emitting sources by using a wide and highly sensitive thermoluminescent (TL) sheet film, which was developed for two-dimensional dose distribution measurements. The TL film is made of Teflon homogeneously mixed with small powders of thermoluminescence (BaSO4:Eu doped). Various dosimetric parameters (i.e., radial dose function, 2D and 1D anisotropy functions) of model 6711 and 6702 125I sources were obtained at various distances from the source surfaces to 15 mm. These parameters obtained with TL sheet were compared with the data recommended in the updated AAPM TG-43 report. The radial dose functions measured with TL sheet are in agreement with those established data of model 6711 125I seed and model 6702 125I seed at most of the distances within 5% and 7%, respectively. All the measured anisotropy functions showed symmetry about the longitudinal source axis. The anisotropy of dose distributions was clearly present in the immediate vicinity of the source edges. The measured 2D anisotropy function values at 1 cm are in reasonably good agreement with the recommended values. The differences at two points in the 1D anisotropy functions measured with TL sheet and the established data at 1 cm from source center were 0.7% and 1.9% for model 6711 and 6702 125I sources, respectively; the differences at 0.5 cm were 1.5% and 1.7% for model 6711 and 6702 125I sources, respectively. The relative dosimetric characteristics in the vicinity of actual interstitial brachytherapy sources containing 125I have been experimentally determined by using the TL sheet as a 2D dosimeter.

Brachytherapy↗

PubMed2003

Biologically effective dose (BED) for interstitial seed implants containing a mixture of radionuclides with different half-lives.

PURPOSE: To develop a tool for evaluating interstitial seed implants that contain a mixture of radionuclides with different half-lives and to demonstrate its utility by examining the clinical implications of prescribing to an isodose surface for such an implant. METHODS AND MATERIALS: A linear-quadratic model for continuous low dose rate irradiation was developed for permanent implants containing a mixture of radionuclides. Using a generalized equation for the biologically effective dose (BED), the effects of cell proliferation and sublethal damage repair were examined systematically for implants containing a mixture of radionuclides. A head-and-neck permanent seed implant that contained a mixture of (125)I and (103)Pd seeds was used to demonstrate the utility of the generalized BED. RESULTS: An equation of BED for implants containing a mixture of radionuclides with different half-lives was obtained. In such an implant, the effective cell kill was shown to depend strongly on the relative dose contributions from each radionuclide type; dose delivered by radionuclides with shorter half-life always resulted in more cell kill for any given sublethal damage repair and cell proliferation rates. Application of the BED formula to an implant containing a mixture of (125)I and (103)Pd seeds demonstrates that the conventional dose prescription to an isodose surface is not unique for such an implant. When the prescription dose was based on existing clinical experience of using (125)I seeds alone, mixing (103)Pd seeds with (125)I seeds would increase the cell kill. On the other hand, if the prescription dose were based on existing clinical experience of using (103)Pd seeds alone, mixing (125)I seeds with (103)Pd seeds in the same implant would create radiobiologically "cold" spots (i.e., an increase in cell survival) at locations where a major portion of the prescription dose is contributed by the (125)I seeds. For fast-growing tumors, these "cold" spots can become significant. CONCLUSIONS: Total dose alone is no longer sufficient for a complete characterization of a permanent seed implant containing a mixture of radionuclides with different half-lives due to the presence of cell proliferation and sublethal damage repair in the protracted dose delivery. BED provides a tool for evaluating the radiobiologic effects of mixing different type of radionuclides in the same implant. When radionuclides of different half-lives are mixed in a permanent implant, using the dose prescription established from existing clinical experience of implants with the longer half-life radionuclide would help to avoid radiobiologic "cold" spots.

Algorithms↗

PubMed2003

Fast high-resolution 3D segmented echo planar imaging for dose mapping using a superheated emulsion chamber.

The superheated emulsion chamber (SEC) consists of superheated droplets of halocarbons in an aqueous gel. The gel resides in a pressure chamber. Brachytherapy sources can be implanted in the SEC for radiation dosimetry studies. Upon irradiation by ionizing radiation, the metastable droplets vaporize to form microbubbles. MRI can be used to determine the distribution of bubbles following irradiation of the SEC. In order to generate sufficient statistical accuracy in the determination of dose distributions around brachytherapy sources, it is necessary to use hundreds of irradiation cycles. Susceptibility-weighted images provide contrast between the gel and the vapor microbubbles. This article describes a 3D, blipped, double-sampled, segmented echo-planar imaging technique for rapidly imaging the SEC at 650 microm isotropic 3D resolution in about 2 min. This method was used with a pressure cycling SEC to acquire hundreds of images in several hours. Results are presented showing the 2D dose distribution generated by an (125)I source as measured in the SEC using this new imaging method.

Brachytherapy↗

PubMed2003

Entropy-based dual-portal-to-3-DCT registration incorporating pixel correlation.

For patient setup verification in external beam radiotherapy (EBRT) of prostate cancer, we developed an information theoretic registration framework, called the minimax entropy registration framework, to simultaneously and iteratively segment portal images and register them to three-dimensional (3-D) computed tomography (CT) image data. The registration framework has two steps, the max step and the min step, and evaluates appropriate entropies to estimate segmentations of the portal images and to find the transformation parameters. In the initial version of the algorithm (Bansal et al. 1999), we assumed image pixels to be independently distributed, an assumption not true in general. Thus, to better segment the portal images and to improve the accuracy of the estimated registration parameters, in this initial formulation of the problem, the correlation among pixel intensities is modeled using a one-dimensional Markov random process. Line processes are incorporated into the model to improve the estimation of segmentation of the portal images. In the max step, the principle of maximum entropy is invoked to estimate the probability distribution on the segmentations. The estimated distribution is then incorporated into the min step to estimate the registration parameters. Performance of the proposed framework is evaluated and compared to that of a mutual information-based registration algorithm using both simulated and real patient data. In the proposed registration framework, registration of the 3-D CT image and the portal images is guided by an estimated segmentation of the pelvic bone. However, as the prostate can move with respect to the pelvic structure, further localization of the prostate using ultrasound image data is required, an issue to be further explored in future.

Algorithms↗

PubMed2003

Dose distributions in bifurcated coronary vessels treated with catheter-based photon and beta emitters in intravascular brachytherapy.

The dose distributions in the bifurcated vessels treated with intravascular brachytherapyline sources are complicated and depend on the bifurcation geometry consisting of a main and a branch vessel at different angles. To investigate the dosimetric effects at the bifurcation, calculations were performed on branching vessels of various bifurcation angles ranging from 20 degrees to 90 degrees. Two catheter based delivery systems were considered in the calculations using a 40 mm long radioactive sources of 192Ir or 90Sr/Y. It was assumed that the bifurcated vessel was treated in twoseparate source insertions, once for the main vessel and later for the branch vessel. Calculations were performed for different values of source gap from 0 to 9 mm, at the junction of main and branch vessels. Our results indicate that main vessel always receives a higher dose (up to 200%) when the branch vessel is also treated. Hot spots at portions of the main vessel near the junction cannot be totally avoided without severely underdosing the branch vessel. For bifurcation angle greater than 45 degrees, a 4 mm source gap can almost ensure that overdosing of the main vessel does not exceed 60% and underdosing of the branch vessel does not exceed 10% for 192Ir. However, for 90Sr/Y, the same is not possible unless the bifurcation angle is larger than 70 degrees. Dose heterogeneity using 90Sr/Y is more sensitive to the value of source gap than 192Ir because 90Sr/Y source provides a sharper dose-fall-off than 192Ir. For both photon and beta emitters, there is no acceptable solution for bifurcation angles less than 30 degrees, where the activity of the line source has a uniform distributions. Appropriate choice of gap at the junction can only help to reduce either overdosing of the main vessel or underdosing of the branch vessel, but not both.

Beta Particles↗

PubMed2003

Commissioning 6 MV photon beams of a stereotactic radiosurgery system for Monte Carlo treatment planning.

The goal of this work is to implement a beam commissioning procedure to generate a multiple source model using a set of standard measurement data for possible Monte Carlo treatment planning in the clinic for a Cyberknife stereotactic radiosurgery system. The required measurement data include the central axis depth dose curve (PDD), the dose profile at dmax(= 1.5 cm) of 60 mm cone at 80 cm source-to-surface distance (SSD), and the cone output factors for cones of 5 mm to 60 mm at 80 cm source-to-axis distance (SAD). The employed dual source model has the same structure as the one that has been studied in our previous work while most of the parameters of each source are extracted from the measurement data rather than the beam phase space. The energy spectra will be extracted from the central axis PDD, the fluence distributions will be deconvoluted from the dose profile at dmax, and the source distributions will be determined from the measured cone output factors. Monte Carlo dose calculations in various water phantoms have been performed to verify the beam commissioning procedure. The agreement between the measurements and the commissioning results was within 2%/1 mm for the central axis PDDs and the dose profiles at various depths when an IC-3 chamber was used and within 2% for the cone output factors for various collimator sizes of 5 to 60 mm. Largest difference (9.5%) was observed for the 7.5 mm cone when an IC-10 chamber was used. The large differences can be attributed to the volumetric averaging effect of the IC-10 chamber, whose dimension is comparable to the field of the small cones. The overall agreement between the measurements and the commissioning results is clinically acceptable, which implies that our commissioning tool is adequate for clinical applications of Monte Carlo dose calculations for the Cyberknife stereotactic radiosurgery system.

Monte Carlo Method↗

PubMed2003

Effect of vitamin C supplementation on oxidative DNA damage in an experimental model of lead-induced hypertension.

AIMS: Chronic exposure to lead results in sustained hypertension in humans and experimental animals. We investigated the possible role of reactive oxygen species (ROS) and their impact on DNA damage in lead-induced hypertension. Further the effect of short-term supplementation of vitamin C is also demonstrated. METHODS: Male Wistar rats were treated with either lead acetate (100 ppm) alone or lead acetate plus vitamin C (20 mg/rat/day). The control rats were fed regular rat chow. Blood pressure, antioxidants, total antioxidant status as measured by ferric-reducing antioxidant power, nitric oxide (NO) metabolites, malondialdehyde (MDA) and 8-hydroxy 2-deoxyguanosine were determined after 0, 1, 2 and 3 months. RESULTS: The lead-exposed group showed a significant rise in blood pressure, lipid peroxidation (MDA) and a substantial oxidative damage to the DNA. A significant fall in NO metabolites, total antioxidant levels and ferric-reducing antioxidant power was also observed in this group. Concomitant administration of vitamin C ameliorated hypertension, normalized NO levels and abrogated lipid peroxidation. Also, it completely prevented oxidative damage to the DNA. CONCLUSIONS: These findings point to enhanced ROS-mediated inactivation and sequestration of NO which can potentially contribute to hypertension, lipid peroxidation, reduced antioxidant status and oxidative DNA damage. The beneficial effects of vitamin C on these parameters support the role of increased ROS activity in the pathogenesis of these abnormalities in this model.

Animals↗

PubMed2002

Edema-induced increase in tumour cell survival for 125I and 103Pd prostate permanent seed implants--a bio-mathematical model.

Edema caused by the surgical procedure of prostate seed implantation expands the source-to-point distances within the prostate and hence decreases the dose coverage. The decrease of dose coverage results in an increase in tumour cell survival. To investigate the effects of edema on tumour cell survival, a bio-mathematical model of edema and the corresponding cell killing by continuous low dose rate irradiation (CLDRI) was developed so that tumour cell surviving fractions can be estimated in an edematous prostate for both 125I and 103Pd seed implants. The dynamic nature of edema and its resolution were modelled with an exponential function V(T) = V(p)(1 + M exp(-0.693T/ T(e))) where V(p) is the prostate volume before implantation, M is the edema magnitude and T(e) is edema half-life (EHL). The dose rate of a radioactive seed was calculated according to AAPM TG43, i.e. D = SkAg(r)phi(an)/r2, where r is the distance between a seed and a given point. The distance r is now a function of time because of edema. The g(r) was approximated as 1/r(0,4) and 1/r(0.8) for 125I and 103Pd, respectively. By expanding the mathematical expression of the resultant dose rate in a Taylor series of exponential functions of time, the dose rate was made equivalent to that produced from multiple fictitious radionuclides of different decay constants and strengths. The biologically effective dose (BED) for an edematous prostate implant was then calculated using a generalized Dale equation. The cell surviving fraction was computed as exp(-alphaBED), where alpha is the linear coefficient of the survival curve. The tumour cell survival was calculated for both 125I and 103Pd seed implants and for different tumour potential doubling time (TPDT) (from 5 days to 30 days) and for edemas of different magnitudes (from 0% to 95%) and edema half-lives (from 4 days to 30 days). Tumour cell survival increased with the increase of edema magnitude and EHL. For a typical edema of a half-life of 10 days and a magnitude of 50%. the edema increased tumour cell survival by about 1 and 2 orders of magnitude for 125I and 103Pd seed implants respectively. At the extreme (95% edema magnitude and an edema half-life of 30 days), the increase was more than 3 and 5 orders of magnitude for 125I and I03Pd seed implants respectively. The absolute increases were almost independent of TPDT and the prostate edema did not significantly change the effective treatment time. Tumour cell survival for prostate undergoing CLDRI using 125I or 103Pd seeds may be increased substantially due to the presence of edema caused by surgical trauma. This effect appears to be more pronounced for 103Pd than 125I because of the shorter half-life of 103Pd. If significant edema is observed post implantation, then a boost to the prostate using external beam radiotherapy may be considered as a part of the treatment strategy.

Brachytherapy↗

PubMed2002

Dosimetric characterization of an encapsulated interstitial brachytherapy source of 125I on a tungsten substrate.

PURPOSE: Recently, a new design of an encapsulated 125I source using a tungsten substrate has been introduced by Best Medical International and named as Best Model 2301 source. In contrast to model 6711 source that uses silver as substrate, the model 2301 source does not yield fluorescent x rays (22.1 keV and 25.5 keV) in the energy range of dosimetric interest. This changes the dosimetric characteristics of the source and experimental determination of these characteristics is needed. METHODS AND MATERIALS: In this work, the dosimetric characteristics of the tungstenbased 125I source were measured using LiF TLDs in a Solid Water phantom. The dose rate constant as well as the radial dose function and anisotropy function were measured. RESULTS: The dose rate constant for the tungsten-based source was determined to be 1.02 +/- 0.07 cGy h(-1) U(-1) in contrast to the previously reported value of 0.98 for the silver-based model 6711 source. The radial dose function for the tungsten-based model 2301 source decreases slightly less rapidly with distance than that for the silver-based model 6711 source. Considerable differences in the anisotropy functions between the two sources were observed. CONCLUSIONS: Dosimetric parameters of the Model 2301 source, based on AAPM TG-43 formalism, have been experimentally determined.

Brachytherapy↗

PubMed2002

Experimental determination of the anisotropy function for the model 200 103Pd "light seed" and derivation of the anisotropy constant based upon the linear quadratic model.

Since the publication of the AAPM Task Group 43 report in 1995, Model 200 103Pd seed, which has been widely used in prostate seed implants and other brachytherapy procedures, has undergone some changes in its internal geometry resulting from the manufacturer's transition from lower specific activity reactor-produced 103Pd ("heavy seeds") to higher specific activity accelerator-produced radioactive material ("light seeds"). Based on previously reported theoretical calculations and measurements, the dose rate constants and the radial dose functions of the two types of seeds are nearly the same and have already been reported. In this work, the anisotropy function of the "light seed" was experimentally measured and an averaging method for the determination of the anisotropy constant from distance-dependent values of anisotropy factors is presented based upon the continuous low dose rate irradiation linear quadratic model for cell killing. The anisotropy function of Model 200 103Pd "light seeds" was measured in a Solid Water phantom using 1 X 1 x 1 mm micro LiF TLD chips at radial distances of 1, 2, 3, 4, 5, and 6 cm and at angles from 0 to 90 degrees with respect to the longitudinal axis of the seeds. At a radial distance of 1 cm, the measured anisotropy function of the 103Pd "light seed" is considerably lower than that of the 103Pd "heavy seed" reported in the TG 43 report. Our measured values at all radial distances are in excellent agreement with the results of a Monte Carlo simulation reported by Weaver, except for points along and near the seed longitudinal axis. The anisotropy constant of the 103Pd "light seed" was calculated using the linear quadratic biological model for cell killing in 30 clinical implants. For the model 200 "light seed," it has a value of 0.865. However, our biological model calculations lead us to conclude that if the anisotropy factors of an interstitial brachytherapy seed vary significantly over radial distances anisotropy constant should not be used as an approximation for anisotropy characteristics of a brachytherapy seed.

Anisotropy↗

PubMed2002

Independent monitor unit calculation for intensity modulated radiotherapy using the MIMiC multileaf collimator.

A self-consistent monitor unit (MU) and isocenter point-dose calculation method has been developed that provides an independent verification of the MU for intensity modulated radiotherapy (IMRT) using the MIMiC (Nomos Corporation) multileaf collimator. The method takes into account two unique features of IMRT using the MIMiC: namely the gantry-dynamic arc delivery of intensity modulated photon beams and the slice-by-slice dose delivery for large tumor volumes. The method converts the nonuniform beam intensity planned at discrete gantry angles of 5 degrees or 10 degrees into conventional nonmodulated beam intensity apertures of elemental arc segments of 1 degree. This approach more closely simulates the actual gantry-dynamic arc delivery by MIMiC. Because each elemental arc segment is of uniform intensity, the MU calculation for an IMRT arc is made equivalent to a conventional arc with gantry-angle dependent beam apertures. The dose to the isocenter from each 1 degree elemental arc segment is calculated by using the Clarkson scatter summation technique based on measured tissue-maximum-ratio and output factors, independent of the dose calculation model used in the IMRT planning system. For treatments requiring multiple treatment slices, the MU for the arc at each treatment slice takes into account the MU, leakage and scatter doses from other slices. This is achieved by solving a set of coupled linear equations for the MUs of all involved treatment slices. All input dosimetry data for the independent MU/isocenter point-dose calculation are measured directly. Comparison of the MU and isocenter point dose calculated by the independent program to those calculated by the Corvus planning system and to direct measurements has shown good agreement with relative difference less than +/-3%. The program can be used as an independent initial MU verification for IMRT plans using the MIMiC multileaf collimators.

Algorithms↗